Curbing the rise of HIV drug resistance in low-income and middle-income countries: the role of dolutegravir-containing regimens

To improve virological suppression and address the emerging threat of HIV drug resistance, many low-income and middle-income countries are moving away from non-nucleoside reverse transcriptase inhibitors (NNRTI) and transitioning to dolutegravir as part of a more affordable and standardised antiretr...

全面介紹

書目詳細資料
Main Authors: Inzaule, SC, Hamers, RL, Doherty, M, Shafer, RW, Bertagnolio, S, Rinke de Wit, TF
格式: Journal article
語言:English
出版: Elsevier 2019